Why some peptides dissolve badly: charge, hydrophobicity and gelling

Net charge, isoelectric point, hydrophobic residue content and beta-sheet self-assembly decide whether a peptide dissolves clear, turns cloudy or gels. The chemistry, read from the sequences we stock.

By Touchstone PeptidesSeptember 22, 20267 minute read

Whether a peptide dissolves clear, turns cloudy or sets into a gel is decided by three properties of its sequence: its net charge at the pH of the solvent, the share of its residues that are hydrophobic, and its tendency to assemble into beta-sheets. Manufacturers sort their solubility guidance by net charge because charge is the property that can be changed with pH. This is chemistry, not a procedure: we do not publish reconstitution guidance, and nothing here names a volume or a step.

Net charge and the isoelectric point

Water dissolves what it can surround with its own dipoles, and it surrounds charged groups best. A peptide's charges come from its ends and its side chains. JPT's solubility note gives the counting rule: "Assign a value of +1 to each basic residue (K, R, H and NH2 at the N-terminus)" and "a value of −1 to each acidic residue (D, E, and COOH at the C-terminus)." An acetylated N-terminus or an amidated C-terminus removes that terminal charge, which is one reason those modifications appear on a sequence line at all (how to read a peptide sequence covers the notation).

The sum of those values is the net charge, and it depends on pH: acidic groups are neutral at low pH and negative above their pKa, basic groups positive at low pH and neutral above theirs. The pH at which the positives and negatives cancel is the isoelectric point, pI. Near it a peptide has the least reason to stay apart from its neighbours. Zapadka and colleagues, reviewing the physical stability of peptide therapeutics, state the rule directly: "Generally, the higher the net charge the slower the aggregation and the lower the net charge the higher the propensity to aggregate," and note that "around the isoelectric point of peptides and proteins, where net charges are essentially zero, then monodisperse and quasi-amorphous aggregates have been observed instead of amyloid-like fibrils." That amorphous aggregate is what a cloudy solution usually is.

Why manufacturers sort their guidance by charge

Bachem's solubility note classifies a peptide as basic when the "number of basic amino acids including the N-terminal amino group > number of acidic amino acids," and as acidic in the reverse case. The logic that follows is pure acid-base chemistry. A basic peptide gains positive charge as the pH falls, because more of its amines and guanidines become protonated, so mildly acidic aqueous conditions push it further from its pI and into solution. An acidic peptide gains negative charge as the pH rises, so mildly basic conditions do the same job for it. A peptide with few charged residues has no charge to exploit, which is why Bachem's note moves peptides "containing a high proportion of polar uncharged amino acids and/or hydrophobic amino acids" into a separate class that relies on a water-miscible organic co-solvent rather than pH.

The same sequence sets two limits on that logic. The acid that dissolves a basic peptide is also the condition under which the bond after an aspartate hydrolyses, and the base that dissolves an acidic peptide is the condition under which a free cysteine thiol oxidizes to a disulfide; freeze-thaw, aliquots and the residues that oxidize covers both. That is why manufacturer guidance is written per peptide, and why the same molecule can carry different notes from different suppliers.

Hydrophobic content

Kyte and Doolittle's 1982 hydropathy scale assigns each residue a value, and averaging it over a sequence gives a single number for how water-avoiding the chain is overall. JPT's note draws a practical line: peptides "with > 25% hydrophobic aa" are the ones that generally cannot be brought into water on charge alone. GenScript's design guide gives the matching rule for people writing sequences rather than dissolving them: "Hydrophobic amino acid content is suggested to be kept below 50% with at least one charged residue incorporated within every five amino acids."

The hydrophobic residues are the ones with aliphatic or aromatic side chains: leucine, isoleucine, valine, phenylalanine, tryptophan, tyrosine, methionine, alanine. In water they do what oil does, and a peptide with a run of them will bury that run against another copy of itself rather than expose it. Proline is the exception that helps: Bachem notes that "dispersed proline residues disrupt secondary structures," which keeps a chain from settling into the flat, layerable shape described next.

Aggregation, beta-sheets and gelling

The most stable way for two extended peptide chains to interact is side by side, hydrogen-bonded backbone to backbone, in a beta-sheet. Layer enough sheets and the assembly is a fibril. Zapadka's review describes the forces: the fibrils "are stabilized by the hydrophobic effect, van der Waals interactions," aromatic ring-to-ring contacts "and hydrogen bonds." The sequence signature of that tendency is short: "A series of five or more residues which all have a high intrinsic propensity form what is known as an aggregation-prone region, APR," and prediction tools such as TANGO and AGGRESCAN score sequences for exactly these regions using hydrophobicity and beta-sheet propensity.

Three variables control how fast it happens. Concentration, first: the review calls the concentration dependence "long-established through numerous kinetic studies on the formation of amyloid fibrils, amorphous aggregates and adsorption on surfaces." pH, second, and not always in the expected direction: GLP-1 forms fibrils at neutral pH, and "at pH > 8.0, GLP-1 follows the more common nucleation-polymerization kinetics ... however, at pH 7.5, the kinetics reverse"; glucagon aggregates both at pH 2.0 and at pH 8.5 to 9.7; salmon calcitonin forms fibrils at neutral pH. Ionic strength, third, because dissolved salt screens the charges that keep chains apart.

A fibril-forming peptide at high enough concentration does not just precipitate; the fibrils can tangle into a network that holds the solvent, and the solution thickens or sets. That is what the word "gelling" describes. It is a physical state, reversible in some systems and not in others, and it is the visible end of the same chemistry that starts with a low net charge and a hydrophobic stretch.

Counter-ions and salt form

The anion that came with the peptide matters too: AmbioPharm notes that salt choice can affect a peptide's stability, solubility and secondary structure. Trifluoroacetate and acetate are the two forms a research vial is likely to carry; TFA salt or acetate salt explains where each comes from and how much of the mass it can be.

Reading the catalog's sequences for solubility

The table applies the rules above to sequences published on our product pages. The net-charge column is the JPT count at a pH where the acidic groups are deprotonated and the amines protonated, with histidine counted as uncharged; it is arithmetic on the sequence, not a measurement.

Peptide	Sequence	Basic sites	Acidic sites	Reading
Cagrilintide	Lipidated amylin analogue, 4409 Da	(full sequence not on our page)		The parent hormone amylin has, in the words of the Novo Nordisk chemists who developed cagrilintide, "a high propensity toward the formation of amyloid fibrils, which makes it a challenging drug design effort"; the analogue was engineered to be "stable, lipidated." Investigational, Phase 3, as of September 21, 2026
AOD-9604	YLRIVQCRSVEGSCGF, cyclic via Cys-Cys	N-terminus, two Arg	Glu, C-terminus	A net positive charge, a disulfide ring, and a run of aliphatic and aromatic residues (Leu, Ile, Val, Phe, Tyr): the ring limits how far the chain can extend into a sheet, the hydrophobic residues are what a co-solvent class exists for
BPC-157	GEPPPGKPADDAGLV	N-terminus, Lys	Glu, two Asp, C-terminus	Net negative; a 2026 review notes that its "three consecutive Pro residues at positions 3-5 disfavour β-sheet conformation"
Epitalon	AEDG	N-terminus	Glu, Asp, C-terminus	A short, strongly acidic peptide with no hydrophobic stretch
Selank	TKPRPGP	N-terminus, Lys, Arg	C-terminus	Net positive, two prolines, no hydrophobic run
Semax	MEHFPGP	N-terminus (His weakly)	Glu, C-terminus	Close to neutral at neutral pH; short and proline-broken
MOTS-c	MRWQEMGYIFYPRKLR	N-terminus, three Arg, Lys	Glu, C-terminus	Net positive, but the Tyr-Ile-Phe-Tyr stretch is the kind of hydrophobic run the APR predictors look for

The pattern is the one the manufacturers' notes encode. Short, charged, proline-broken sequences (Selank, Semax, epitalon, the bioregulator tetrapeptides) have every structural reason to dissolve clear. Long sequences with a hydrophobic stretch and a documented fibril-forming parent (cagrilintide, and the GLP-1 class generally) are the ones formulation chemists spend years on, and they are the peptides for which a research vial's solubility note from the manufacturer deserves to be read rather than assumed.

Sources

For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.

Two things before you come in.